Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with unfractionated heparin plus eptifibatide but increased bleeding among patients with non–ST-segment elevation acute coronary syndromes ...
Sep 1, 2013
0
0
A new study published in Restorative Neurology and Neuroscience demonstrates that Chinese herbal medicine Ji-Sui-Kang (JSK), given systemically for three weeks after injury in rats, improved locomotor function, reduced tissue ...
Aug 19, 2013
0
1
Wine and beer in moderate doses may protect against venous thrombosis, but consumption of more than 14 standard drinks per week increases the risk of the same condition, in particular pulmonary embolism, in both men and women, ...
Jul 4, 2013
0
0
Simultaneously elevated levels of the biomarkers C-reactive protein, fibrinogen and leukocyte count in individuals with chronic obstructive pulmonary disease (COPD) were associated with increased risk of having exacerbations, ...
Jun 11, 2013
0
0
(HealthDay)—Intensive glucose-lowering therapy (INT) is associated with favorable changes in lipoprotein levels and inflammatory risk factors even though it does not lower the incidence of cardiovascular events, according ...
Apr 15, 2013
0
0
A study published today in BioMed Central's open access journal Skeletal Muscle reports of a new therapeutic technique to repair and rebuild muscle for sufferers of degenerative muscle disorders. The therapy brings together ...
Nov 26, 2012
0
0
(HealthDay)—Among people at high risk for cardiovascular disease, knowing their blood levels of two specific markers for inflammation might help prevent a heart attack or stroke, according to British investigators.
Oct 4, 2012
0
0
Two large international meta-analyses published Online First in The Lancet provide compelling new evidence that interleukin-6 receptor (IL6R), a protein involved in inflammatory signaling, has a causal role in the development ...
Mar 13, 2012
0
0
